Digipath to Provide Product Testing for Redwood Cultivation Products, Including Mike Tyson's New Ear Shaped Gummies, 'Mike Bites'
April 04 2022 - 8:15AM
InvestorsHub NewsWire
LAS VEGAS, NV -- April 4, 2022 -- InvestorsHub NewsWire
-- Digipath, Inc. (OTCQB:
DIGP) (“Digipath” or the “Company”), a
service-oriented independent analytical testing laboratory, data
analytics firm focused on the cannabis and hemp markets is pleased
to announce that it has been selected by Redwood Cultivation as its
Nevada testing lab. Redwood is a Nevada licensed cultivator with a
20,000 sq. ft., state of the art cultivation facility that uses a
fully automated fertilization, drip irrigation, HVAC, lighting, and
Co2 system.
Digipath will administer the state required testing on products
that Redwood manufacturers including popular brands from cannabis
legends Tommy Chong (Tommy Chong’s Cannabis) and Willie Nelson
(Willie’s Reserve.) Digipath will also start testing Mike Tyson’s
‘Tyson Ranch’ products including the new “Mike Bites” ear shaped cannabis
gummies which evoke memories of Tyson’s infamous ear
biting incident during his fight with Evander Holyfield.
“We are honored to be selected by Redwood Cultivation to test
their incredibly popular product line,” stated Digipath Founder and
President Todd Denkin. “These are significant cannabis brands with
tremendous followings. Paul has always run a tight ship over at
Redwood and we’re excited about the opportunity.”
“We are pleased to work with Digipath to provide the required
testing for our product line,” said Paul Schloss, Owner and
President at Redwood. “Digipath has always delivered on time and on
budget and is a well-established high-quality testing facility that
is extremely helpful and has a record for consistency.”
About Digipath, Inc. (OTCQB:
DIGP)
Digipath, Inc., supports the
cannabis industry’s best practices for reliable testing, data
acquisition, formulations, and new canna-tech to the cannabis
industry. The “Digipath Data Vault” is a rich data set of over
70,000 cannabis chemo profiles which can be used for research and
product development in a wide variety of applications.
Digipath Labs provides
pharmaceutical-grade analysis and testing to the cannabis industry
to ensure producers, consumers and patients know exactly what is in
the cannabis they ingest and to help maximize the quality of its
clients’ products through analysis, research, development, and
standardization.
Information about Forward-Looking
Statements
This press release contains “forward-looking statements” that
include information relating to future events. Forward-looking
statements should not be read as a guarantee of future performance
or results and will not necessarily be accurate indications of the
times at, or by, which that performance or those results will be
achieved. Forward-looking statements are based on information
available at the time they are made and/or management's good faith
belief as of that time with respect to future events and are
subject to risks and uncertainties that could cause actual
performance or results to differ materially from those expressed
in, or suggested by, the forward-looking statements. Important
factors that could cause these differences include, but are not
limited to: the Company's inability to consummate the closing of
the Steep Hill acquisition, need for additional funding, the demand
for the Company's products, governmental regulation of the cannabis
industry, the Company's ability to maintain customer and strategic
business relationships, the impact of competitive products and
pricing, growth in targeted markets, the adequacy of the Company's
liquidity and financial strength to support its growth, and other
risks that may be detailed from time-to-time in the Company's
filings with the United States Securities and Exchange Commission.
For a more detailed description of the risk factors and
uncertainties affecting Digipath, please refer to the Company's
recent Securities and Exchange Commission filings, which are
available at www.sec.gov. The Company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
as a result of new information, future events, or otherwise.
Corporate Contact:
Digipath, Inc.
702-527-2060
Investor Relations & Financial Media
Integrity Media
team@integritymedia.com
Toll Free: (888) 216-3595
www.IntegrityMedia.com
Digipath (PK) (USOTC:DIGP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Digipath (PK) (USOTC:DIGP)
Historical Stock Chart
From Apr 2023 to Apr 2024